Catalyst Wire Dossier Catalyst Wire Dossier

GANCICLOVIR

GANCICLOVIR SODIUM · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for GANCICLOVIR, covering 2006-09-13 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC) [Phase 2]

See pricing